Cost-Containment

The framework links U.S. drug prices to international benchmarks through manufacturer agreements and federal pricing mechanisms, with major implications for high-cost drugs like GLP-1s.

For employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.

A stop-loss market veteran looks at the differences between the two types of ERISA self-funded plans.

The move might, or might not, affect employers that fail to offer enough affordable major medical coverage.

The Idaho Farm Bureau Federation asked EBSA to assess a health coverage purchasing strategy it has proposed for its 10,770 members.

It's a critical time for employees who are trying to make the best financial decisions for themselves and their families, with the pressures of health care costs, and financial planning for the new year all amplifying that stress.